WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

Kenneth Kwok  1     Severine Vermeire  2     Irene Modesto  3     David T. Rubin  4     Silvio Danese  5     Siew C. Ng  6     Nana Koram     Thomas V Jones    
1 Pfizer Inc,New York,United States
2 University Hospitals Leuven,Leuven,Belgium
3 Pfizer Inc,New Yor,United States
4 University of Chicago Medicine Inflammatory Bowel Disease Center,Chicago,United States
5 Humanitas University,Milan,Italy
6 LKS Institute of Health Science, Chinese University of Hong Kong, Institute of Digestive Disease,Hong

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing